Community-acquired pneumonia

Community-acquired pneumonia ( engl. community- acquired pneumonia (CAP ) ) determines such pneumonia, the causative pathogen were taken outside the hospital.

The classification divides Applied pneumonia after a clinically practical point of view. She found her establishment after a publication by M. Woodhead in 1997. Afterwards there beside of community-acquired pneumonia ( CAP), nosocomial pneumonia (English hospital- acquired pneumonia ( HAP) ), pneumonia a ventilated patient (german fan -associated pneumonia (VAP) ), and pneumonia the patient immunocompromised. It can make a forecast for the disease process be issued.

Properties

According to the above classification, the putative causative agent of pneumonia spectrum can be estimated and the calculated antibiotic therapy can be aligned afterwards. The most common pathogens ( Update 3/ 2013) are Streptococcus pneumoniae and Haemophilus influenzae.

Importance

As a major national epidemic (incidence 2-5 per 1000), the community-acquired pneumonia is the subject of investigations by the Competence Network for Community-acquired pneumonia ( CAPNETZ ), which is funded by the Federal Ministry of Education and Research.

Since 2005, the community-acquired pneumonia consulted in accordance with Decision of the Federal Committee on requiring documentation services for the external quality assurance of hospitals, which is managed professionally by the federal office quality assurance. The mission of the BQS this ended in 2010 and was acquired by the AQUA- Institute.

Further Reading

  • JA Ramirez, AR Anzueto: Changing needs of community- acquired pneumonia. In: Journal of Antimicrobial Chemotherapy. Volume 66 Suppl 3, April 2011, p iii3 - III9, ISSN 1460-2091. doi: 10.1093/jac/dkr094. PMID 21,482,567th PMC 3143426 (Free full text ). (Review).
  • Pletz MW, G. Rohde et al: Etiology and management of the CAP for the clinical practice. In: German medical weekly. Volume 136, Number 15, April 2011, pp. 775-780, ISSN 1439-4413. doi: 10.1055/s-0031-1275806. PMID 21,469,047th (Review).
  • Bartlett JG: Diagnostic tests for agents of community- acquired pneumonia. In: Clinical Infectious Diseases. Volume 52 Suppl 4, May 2011, pp. S296 - S304, ISSN 1537-6591. doi: 10.1093/cid/cir045. PMID 21,460,288th (Review).
  • S. Butt, E. Swiatlo: Treatment of community- acquired pneumonia in ambulatory setting to. In: The American journal of medicine. Volume 124, Number 4, April 2011, pp. 297-300, ISSN 1555-7162. doi: 10.1016/j.amjmed.2010.06.027. PMID 21,435,417th (Review).
  • E. Polverino, A. Torres Marti: community - acquired pneumonia. In: Minerva anestesiologica. Volume 77, Number 2, February 2011, pp. 196-211, ISSN 1827-1596. PMID 21,242,952th (Review).
  • NK Brar, MS Niederman: Management of community- acquired pneumonia: a review and update. In: Therapeutic advances in respiratory disease. Volume 5, Number 1, February 2011, pp. 61-78, ISSN 1753-4666. doi: 10.1177/1753465810381518. PMID 20,935,033th (Review).
  • M. Christ - Crain, SM Opal: Clinical review: the role of biomarkers in the diagnosis and management of community- acquired pneumonia. In: Critical care (London, England). Volume 14, Number 1, 2010, pp. 203, ISSN 1466 - 609x. doi: 10.1186/cc8155. PMID 20,236,471th PMC 2.87548 million ( free full text ). (Review).
Immunosuppression Digital Object Identifier
55433
de